Scilex Holding (SCLXW) Interest Coverage Ratio (2021 - 2026)
Scilex Holding (SCLXW) recorded quarterly Interest Coverage Ratio of 8.51 in Q1 2026, up 73.2% quarter-over-quarter from 31.76 in Q4 2025, and up 24.3% on a YoY basis from 6.85 in Q1 2025.
Scilex Holding (SCLXW) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Scilex Holding's Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 8.51 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 24.3% year-over-year to 8.51; the TTM figure through Mar 2026 stood at 27.46 (down 17.02% YoY), while the FY2025 annual figure was 30.2, up 28.93% from the prior year.
- Interest Coverage Ratio was 8.51 for Q1 2026 at Scilex Holding, up from 31.76 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 4.83 in Q1 2023 to a low of 1385.39 in Q2 2022.
- Historically, Interest Coverage Ratio has averaged 178.46 across 5 years, with a median of 31.76 in 2025.
- Biggest YoY gain for Interest Coverage Ratio was 99.59% in 2023; the steepest drop was 1223.9% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 19.58 in 2022, then sank by 69.95% to 33.28 in 2023, then sank by 199.17% to 99.57 in 2024, then soared by 68.11% to 31.76 in 2025, then surged by 73.2% to 8.51 in 2026.
- The last three Interest Coverage Ratio figures came in at 8.51 (Q1 2026), 31.76 (Q4 2025), and 66.66 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Scilex Holding | - | - | 4.15 Mn | -8.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.51 |
| Dec 31, 2025 | -31.76 |
| Sep 30, 2025 | -66.66 |
| Jun 30, 2025 | -7.65 |
| Mar 31, 2025 | -11.24 |
| Dec 31, 2024 | -99.57 |
| Sep 30, 2024 | -34.58 |
| Jun 30, 2024 | -27.36 |
| Mar 31, 2024 | -36.68 |
| Dec 31, 2023 | -33.28 |
| Sep 30, 2023 | -75.64 |
| Jun 30, 2023 | -5.94 |
| Mar 31, 2023 | -4.83 |
| Dec 31, 2022 | -19.58 |
| Sep 30, 2022 | -5.71 |
| Jun 30, 2022 | -1,385.39 |
| Mar 31, 2022 | -1,179.48 |
| Dec 31, 2021 | -704.35 |